Viewing Study NCT00132067


Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2026-01-01 @ 7:52 AM
Study NCT ID: NCT00132067
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2005-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module